10/27/2008
High-Level Summary of All Part D Application Revisions from 2009 Version of Part D Application to 2010 Version
Clarification |
Purpose of the Clarification |
Application |
|||||||
PDP
|
MA-PD |
Cost |
800 series (PDP and Cost) |
Directs (PDP and MA-PD) |
PACE |
||||
GENERAL INFORMATION and INSTRUCTIONS |
|||||||||
1. Updated dates (language where appropriate) and regulatory and Prescription Drug Benefit Manual references for each attestation section. |
Updated dates (language where appropriate) and references to statutes, regulations and Part D guidance.
|
Through-out document |
Through-out document |
Through-out document |
Through-out document |
Through-out document |
Through-out document |
||
2. Clarified instructions related to the application submission and correction process. |
Clarified instructions related to the courtesy opportunity to cure deficiencies, the Notice of Intent to Deny process to cure deficiencies, and the retail pharmacy access review process. |
Instructions |
Instructions |
Instructions |
Instructions |
Instructions |
Instructions |
||
3. Clarify dates on the calendar for courtesy cure period and Notices of Intent to Deny. |
In response to comments received, CMS will include the dates of the cure periods. |
Instructions |
Instructions |
Instructions |
Instructions |
Instructions |
Instructions |
||
APPLICANT EXPERIENCE, CONTRACTS, LICENSURE AND FINANCIAL STABILITY |
|||||||||
4. Clarified contractual requirements related to the MMA and Compliance regulations. |
|
3.1.1D8 3.1.1D11 3.1.1D13 |
3.1.1D8 3.1.1D11 3.1.1D13 |
3.1.1D8 3.1.1D11 3.1.1D13 |
N/A |
N/A |
Mgmt & Operations |
||
5. Added contractual requirements to reflect the enactment of the Medicare Improvements for Patients and Providers Act of 2008 (MIPPA) |
Based on sections 171 and 173 of MIPPA all Part D sponsors are required to include contractual provisions that relate to prompt payment and notice of reimbursement standard updates. |
3.1.1D17 3.1.1D18 |
3.1.1D17 3.1.1D18 |
3.1.1D17 3.1.1D18 |
N/A |
N/A |
Mgmt & Ops |
||
Formulary/Pharmacy and Therapeutics (P&T) Committee |
|||||||||
6. Amend attestation to reflect submission of transition policies directly to HPMS instead of through CMS-formulary website. |
Existing attestation required initial applicants to provide the transition policy to CMS through a website on the formulary due date. Automation will now require the transition policy be submitted directly to new HPMS module. |
3.2.1A6 |
3.2.1A6 |
3.2.1A6 |
N/A |
N/A |
Formulary/P&T Committee |
||
BIDS |
|||||||||
7. Deleted attestation related to submitting meaningful and distinct bids. |
The attestation is only applicable to stand-alone PDPs and should not be applied to other types of Part D sponsors. |
N/A |
3.2.6 |
3.2.6 |
N/A |
N/A |
N/A |
||
APPENDICES |
|||||||||
8. Updated language throughout Application to Request Federal Waiver of State Licensure Requirement for Prescription Drug Plan. |
Clarified language related to the dates of submission for the waiver application in conjunction with the Part D application. |
Appendix I
|
N/A |
N/A |
N/A |
N/A |
N/A |
||
9. Clarified language in contract templates to properly address the MMA and compliance regulations. |
|
Appendices III-VIII |
Appendices II-VII |
Appendices II-VII |
N/A |
N/A |
Mgmt & Operations |
||
10. Added language to address the enactment of MIPPA. |
Based on section 171 of MIPPA all Part D sponsors are required to include contractual provisions that relate to prompt payment with its PBM, retail, home infusion, and ITU pharmacies. |
Appendices III, IV, VI, VIII |
Appendices II, III, V, VII |
Appendices II, III, V, VII |
N/A |
N/A |
Mgmt & Ops |
||
11. Added language to address the enactment of MIPPA. |
Based on section 173 of MIPPA all Part D sponsors are required to include contractual provisions that relate to notice of reimbursement standard updates. |
Appendices III-VIII |
Appendices II-VII |
Appendices II-VII |
N/A |
N/A |
Mgmt & Ops |
||
12. Added language to address the finalization of a home infusion contractual requirement based on the Policy and Technical Regulation. |
Based on the final approval in April 2008 of the Policy and Technical correction regulation, all Part D sponsors are required to include a contractual provision related to the delivery of home infusion drugs within 24 hours of discharge. |
Appendix VI |
Appendix V |
Appendix V |
N/A |
N/A |
N/A |
||
13. Added language to address the enactment of MIPPA. |
Based on section 172 of MIPPA all Part D sponsors are required to include contractual provisions with long-term care pharmacies that related to timeframes for claims submission. |
Appendix VII |
Appendix VI |
Appendix VI |
N/A |
N/A |
Mgmt & Ops |
File Type | application/msword |
File Title | OMB Application Review Table |
Author | Marla Rothouse |
Last Modified By | Marla Rothouse |
File Modified | 2008-10-27 |
File Created | 2008-10-14 |